← FDA Drug Approvals (Drugs@FDA)
NOREPINEPHRINE BITARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2018-10-04
Drug application
- FDA Application #
ANDA211242- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NOREPINEPHRINE BITARTRATE
- Generic name
- NOREPINEPHRINE BITARTRATE
- Active ingredients
- NOREPINEPHRINE BITARTRATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MYLAN LABS LTD
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2018-10-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown